Cargando…
Statins attenuate outgrowth of breast cancer metastases
BACKGROUND: Metastasis in breast cancer foreshadows mortality, as clinically evident disease is aggressive and generally chemoresistant. Disseminated breast cancer cells often enter a period of dormancy for years to decades before they emerge as detectable cancers. Harboring of these dormant cells i...
Autores principales: | Beckwitt, Colin H., Clark, Amanda M., Ma, Bo, Whaley, Diana, Oltvai, Zoltán N., Wells, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220112/ https://www.ncbi.nlm.nih.gov/pubmed/30401978 http://dx.doi.org/10.1038/s41416-018-0267-7 |
Ejemplares similares
-
Statin drugs to reduce breast cancer recurrence and mortality
por: Beckwitt, Colin H., et al.
Publicado: (2018) -
Concomitant attenuation of HMG-CoA reductase expression potentiates the cancer cell growth-inhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics
por: Ishikawa, Takuro, et al.
Publicado: (2018) -
Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion
por: Warita, Katsuhiko, et al.
Publicado: (2014) -
Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling
por: Beckwitt, Colin H., et al.
Publicado: (2018) -
Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells
por: Dioufa, Nikolina, et al.
Publicado: (2017)